TSCAN THERAPEUTICS INC (TCRX) Forecast, Price Target & Analyst Ratings

NASDAQ:TCRX • US89854M1018

1.12 USD
+0.04 (+3.7%)
Last: Mar 5, 2026, 01:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TSCAN THERAPEUTICS INC (TCRX).

Forecast Snapshot

Consensus Price Target

Price Target
$7.14
+ 537.50% Upside

Next Earnings Forecast

Earnings Estimate
Release DateMar 11, 2026
PeriodQ4 / 2025
EPS Estimate-$0.25
Revenue Estimate2.089M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.14
Upside
+ 537.50%
From current price of $1.12 to mean target of $7.14, Based on 13 analyst forecasts
Low
$4.04
Median
$6.12
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
10.53%

Price Target Summary

13 analysts have analysed TCRX and the average price target is 7.14 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.12.
The average price target has been revised upward by 10.53% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TCRX Current Analyst RatingTCRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

TCRX Historical Analyst RatingsTCRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
TCRX was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TCRX.
In the previous month the buy percentage consensus was at a similar level.
TCRX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05WedbushMaintains Outperform -> Outperform
2025-11-13HC Wainwright & Co.Maintains Buy -> Buy
2025-11-04BTIGDowngrade Buy -> Neutral
2025-11-04NeedhamMaintains Buy -> Buy
2025-05-07HC Wainwright & Co.Maintains Buy -> Buy
2025-04-08NeedhamReiterate Buy -> Buy
2025-03-07BarclaysMaintains Overweight -> Overweight
2025-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-05NeedhamMaintains Buy -> Buy
2024-12-11NeedhamReiterate Buy -> Buy
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-12NeedhamReiterate Buy -> Buy
2024-11-06NeedhamReiterate Buy -> Buy
2024-08-13WedbushReiterate Outperform -> Outperform
2024-08-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12NeedhamReiterate Buy -> Buy
2024-06-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16BTIGInitiate Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-13NeedhamReiterate Buy -> Buy
2024-04-23WedbushReiterate Outperform -> Outperform
2024-03-07BarclaysMaintains Overweight -> Overweight
2024-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-01WedbushReiterate Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release DateMar 11, 2026
PeriodQ4 / 2025
EPS Estimate-$0.25
Revenue Estimate2.089M
Revenue Q2Q214.14%
EPS Q2Q18.00%
Number of Analysts9

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

TCRX is expected to report earnings on 3/11/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 2.09M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TCRX revenue by date.TCRX revenue by date.
13.54M
33.53%		21.049M
55.46%		2.816M
-86.62%		10.893M
286.83%		8.033M
-26.26%		13.636M
69.75%		20.716M
51.92%		53.004M
155.86%		93.712M
76.80%		226.39M
141.58%		336.86M
48.80%		437.62M
29.91%
EBITDA
YoY % growth
TCRX ebitda by date.TCRX ebitda by date.
-61.5M
-35.73%		-88.097M
-43.25%		-130.713M
-48.37%		-131.652M
-0.72%		-140.998M
-7.10%		-151.247M
-7.27%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TCRX ebit by date.TCRX ebit by date.
-66.64M
-37.01%		-93.458M
-40.24%		-134.821M
-44.26%		-144.587M
-7.24%		-121.808M
15.75%		-132.313M
-8.62%		-132.178M
0.10%		-88.491M
33.05%		-29.858M
66.26%		50.141M
267.93%		134.93M
169.10%		184.76M
36.93%
Operating Margin
TCRX operating margin by date.TCRX operating margin by date.
-492.17%-444.00%-4,787.68%-1,327.34%-1,516.34%-970.32%-638.05%-166.95%-31.86%22.15%40.06%42.22%
EPS
YoY % growth
TCRX eps by date.TCRX eps by date.
-2.75
59.08%		-1.89
31.27%		-1.15
39.15%		-1.10
4.68%		-0.91
16.70%		-0.87
4.60%		-0.93
-7.14%		-0.61
34.97%		-0.19
68.07%		0.31
257.89%		0.78
153.33%		1.03
32.24%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.25
18.00%		-0.20
24.28%		-0.20
26.96%		-0.21
24.50%		-0.20
17.21%
Revenue
Q2Q % growth		2.089M
214.14%		2.55M
17.46%		1.913M
-37.81%		1.785M
-28.91%		1.53M
-26.76%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-32.299M
12.02%		-28.891M
20.30%		-29.361M
24.04%		-30.532M
17.60%		-29.886M
7.47%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TCRX Yearly Revenue VS EstimatesTCRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
TCRX Yearly EPS VS EstimatesTCRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.51%
EPS Next 5 Year
8.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
56.74%
Revenue Next 5 Year
71.81%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-3.95%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TSCAN THERAPEUTICS INC / TCRX Forecast FAQ

What is the average price target for TSCAN THERAPEUTICS INC (TCRX) stock?

13 analysts have analysed TCRX and the average price target is 7.14 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.12.


When does TSCAN THERAPEUTICS INC (TCRX) report earnings?

TSCAN THERAPEUTICS INC (TCRX) will report earnings on 2026-03-11, after the market close.


What are the consensus estimates for TSCAN THERAPEUTICS INC (TCRX) next earnings?

The consensus EPS estimate for the next earnings of TSCAN THERAPEUTICS INC (TCRX) is -0.25 USD and the consensus revenue estimate is 2.09M USD.


Can you provide the expected long term growth rate for TSCAN THERAPEUTICS INC stock?

The expected long term growth rate for TSCAN THERAPEUTICS INC (TCRX) is 56.74%.